Companies: 10,795·Total market cap: $144.5T

Legend Biotech Corporation

Legend Biotech Corporation

LEGNNASDAQHealthcare● Active

$32.62

$-1.58(-4.62%)

Market Cap$6.0B

P/E Ratio—

52W High$45.297

52W Low$16.24

Avg Volume2.3M

Open$34.86

Beta0.35

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Legend Biotech Corporation（LEGN）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · LEGN · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-1.36Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$1.1BFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding184.3MShares outstanding history

Next EarningsAug 10, 2026Est.Earnings history

探索 Legend Biotech Corporation 数据

分析师预测$60 · Buy

股息不分红

营收$1.0B+64.04%

盈利EPS $-1.60-64.95%

财务快照

FY 2025Revenue$1.03B▲ +64.04% YoY

202320242025

FY 2025Net Income-$296.8M▼ 67.66% YoY

202320242025

FY 2025EPS$-1.60▼ 64.95% YoY

202320242025

TTM:Revenue: $1.14BNet Income: -$250.2MEPS: $-1.36View income statement →

分析师评级与目标价

Buy19 位分析师

Strong Buy

0

Buy

16

Hold

3

Sell

0

Strong Sell

0

12-Month Price Target

$24.00Low

$32.62Current

$59.78Avg Target上涨空间 83.26%

$75.00High

合计: 19 · 买入占比: 84.2%

根据过去 3 个月内 19 位华尔街分析师，LEGN 共识评级为 Buy，12 个月平均目标价 $59.78 （较现价 $32.62 上涨空间 83.26%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Legend Biotech Corporation

$32.62-4.62%$6.0B #2

Ascentage Pharma Group International

$17.20-5.91%$399.7M #3

Adaptive Biotechnologies Corporation

$16.90-6.53%$2.7B #4

$88.28-4.53%$4.3B #5

CG Oncology, Inc. Common stock

$53.72-4.23%$4.7B #6

IDEAYA Biosciences, Inc.

$28.29-3.18%$2.5B

股票表现

1D-4.62%

1W-6.75%

1M+16.00%

3M+71.96%

YTD+50.05%

1Y-6.21%

5Y-16.14%

关于 Legend Biotech Corporation

CEOYing Huang

IPO DateJun 5, 2020

Employees2,600

CountryUS

Websitelegendbiotech.com

Legend Biotech Corporation a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in…

Biotechnology HealthcareNASDAQADRUS

关于股票概览与关键数据

Legend Biotech Corporation（LEGN）是 Biotechnology 行业的 Healthcare 类公司，于 Jun 5, 2020 在 NASDAQ 上市。截至最近交易日，LEGN 股价为 $32.62，市值约为 $6.0B。过去12个月累计回报 -6.21%，年初至今回报 +50.05%。

根据 19 位华尔街分析师，Legend Biotech Corporation 股票共识评级为Buy，12个月平均目标价为 $59.78。2025 财年 Legend Biotech Corporation 营收 $1.0B，净利润 -$296.8M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Legend Biotech Corporation（LEGN）股价为 $32.62，在 NASDAQ 上市，52周区间为 $16.24 – $45.30。

LEGN 最新股价LEGN quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议